Skip to main content

Advertisement

SpringerLink
Log in

Severe hepatitis B virus reactivation related to ibrutinib monotherapy

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wiestner A (2013) Targeting B-cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies. J Clin Oncol 31:128–130

    Article  CAS  PubMed  Google Scholar 

  2. Sun C, Tian X, Lee YS et al (2015) Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood 126:2213–2219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Reddy KR, Beavers KL, Hammond SP et al (2015) American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 148:215–219 quiz e216-217

    Article  CAS  PubMed  Google Scholar 

  4. de Jesus Ngoma P, Kabamba B, Dahlqvist G et al (2015) Occult HBV reactivation induced by ibrutinib treatment: a case report. Acta Gastroenterol Belg 78:424–426

    Google Scholar 

Download references

Author contributions

YH, HK, and AP wrote the paper.

Author information

Authors and Affiliations

  1. Department of Hematology, Tel-Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Yair Herishanu

  2. Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

    Helena Katchman

  3. Hebrew University Medical School, Jerusalem, Israel

    Aaron Polliack

Authors
  1. Yair Herishanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helena Katchman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aaron Polliack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yair Herishanu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herishanu, Y., Katchman, H. & Polliack, A. Severe hepatitis B virus reactivation related to ibrutinib monotherapy. Ann Hematol 96, 689–690 (2017). https://doi.org/10.1007/s00277-016-2917-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2917-2

Keywords

Search

Navigation